Global drinks can manufacturer Rexam has agreed to sell its pharmaceutical devices and prescription retail packaging units to Montagu Private Equity for $805m.
The two business units employed 1,500 people and recorded sales of £250m in 2012.
Go deeper with GlobalData
The transaction is subject to consultation with several European works councils. It would be completed in mid-2014.
Rexam plans to return approximately £450m to shareholders from the sale through a redeemable B share scheme along with a share consolidation.
Rexam CEO Graham Chipchase said that the sale of its healthcare business divisions is part of a plan to maximise shareholder value.
"The pharmaceutical devices and prescription retail packaging divisions represent the majority of the value of our healthcare business," Chipchase added.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"Following the sale of healthcare, we will be a focused beverage cans business with a strong financial position."
Rexam is also holding talks regarding the sale of its closures and containers division, which makes plastic bottles for over-the-counter medicine.
